The Centers for Medicare and Medicaid Services has released final guidance on the process for the second cycle of drug price negotiations.
Category: Pharma, Health and Wellness, Disease management, Life Sciences, Patient Access, Legislation, Medicare and Medicaid, Care, Public Policy
